Constellation Pharmaceuticals (CNST) PT Reduced to $53 at Jefferies due to CPI-1205 Stoppage

July 20, 2020 6:53 AM EDT Send to a Friend
Jefferies analyst Maury Raycroft assumed coverage and lowered the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $53.00 (from $63.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login